Preclinical and clinical studies demonstrate that co-administration of these peptides achieves superior reductions in bodyweight, appetite, and fasting glucose than either agent aloneachieving up to a 17% reduction in bodyweight in non-diabetic individuals and a 15.6% reduction in patients with type 2 diabetes over 2032 weeks
The name describes the assay that found it, not a confirmed therapeutic effect
Its primary mechanism is angiogenesis: BPC-157 helps trigger new blood vessel growth in injured tissue, which is what allows it to support repair in tendons, ligaments, the gut lining, and joints
It also modulates dopaminergic and serotonergic pathways in animal neurobehavior studies
2024, ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/
Together: AOD gets the fat out of storage, MOTS-C ensures the downstream metabolism handles it efficiently